Health Catalyst Stock News

Health Catalyst, Inc. (NASDAQ:HCAT) CEO Daniel D. Burton sold 21,972 shares of the stock in a transaction that occurred on Monday, December 6th. The shares were sold at an average price of $40.06, for a total transaction of $880,198.32. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is []

Related Stocks: HCAT ,

Health Catalyst, Inc. (NASDAQ:HCAT) CEO Daniel D. Burton sold 21,972 shares of Health Catalyst stock in a transaction that occurred on Monday, December 6th. The stock was sold at an average price of $40.06, for a total transaction of $880,198.32. The transaction was disclosed in a legal filing with the SEC, which is available through []

Health Catalyst, Inc. (NASDAQ:HCAT) Equities researchers at Jefferies Financial Group issued their FY2021 earnings estimates for shares of Health Catalyst in a research report issued on Wednesday, December 1st. Jefferies Financial Group analyst G. Santangelo expects that the company will post earnings per share of ($1.95) for the year. Jefferies Financial Group currently has []

Health Catalyst, Inc. (NASDAQ:HCAT) General Counsel Daniel H. Orenstein sold 4,633 shares of the businesss stock in a transaction that occurred on Monday, December 6th. The shares were sold at an average price of $38.35, for a total transaction of $177,675.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, []

Health Catalyst, Inc. (NASDAQ:HCAT) CEO Daniel D. Burton sold 36,212 shares of the firms stock in a transaction dated Friday, December 3rd. The shares were sold at an average price of $40.62, for a total transaction of $1,470,931.44. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available []

Conestoga Capital Advisors LLC lessened its stake in Health Catalyst, Inc. (NASDAQ:HCAT) by 0.7% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 316,044 shares of the companys stock after selling 2,335 shares during the period. Conestoga Capital Advisors []

Health Catalyst Inc. (NASDAQ:HCAT) concluded the trading at $38.90 on Friday, December 03 with a fall of -9.03% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $42.76 and 5Y monthly beta was reading 0.65 with its price kept floating in the Health Catalyst Inc. (HCAT) Sits On Its Hands At $38.90 Read More »

Health Catalyst, Inc. (NASDAQ:HCAT)s share price gapped down before the market opened on Friday . The stock had previously closed at $42.76, but opened at $41.11. Health Catalyst shares last traded at $40.49, with a volume of 4,924 shares traded. Several equities analysts have recently issued reports on HCAT shares. Zacks Investment Research lowered Health []

Grom Social Enterprises (NASDAQ:GROM) and Health Catalyst (NASDAQ:HCAT) are both computer and technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, institutional ownership, profitability, dividends, analyst recommendations and valuation. Earnings & Valuation This table compares Grom Social Enterprises and Health Catalyst’s top-line […]

Jefferies Financial Group initiated coverage on shares of Health Catalyst (NASDAQ:HCAT) in a report released on Wednesday morning, The Fly reports. The firm issued a hold rating on the stock. A number of other equities research analysts have also commented on HCAT. BTIG Research assumed coverage on Health Catalyst in a research report on Thursday, []

SALT LAKE CITY, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organization

Wall Street analysts expect that Health Catalyst, Inc. (NASDAQ:HCAT) will post sales of $63.18 million for the current quarter, according to Zacks Investment Research. Six analysts have provided estimates for Health Catalysts earnings, with the highest sales estimate coming in at $63.76 million and the lowest estimate coming in at $62.86 million. Health Catalyst posted []

Equities analysts predict that Health Catalyst, Inc. (NASDAQ:HCAT) will announce earnings of ($0.21) per share for the current fiscal quarter, according to Zacks Investment Research. Six analysts have provided estimates for Health Catalysts earnings, with the highest EPS estimate coming in at ($0.14) and the lowest estimate coming in at ($0.34). Health Catalyst reported earnings []

Health Catalyst (NASDAQ:HCAT) and Magnite (NASDAQ:MGNI) are both mid-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, profitability, institutional ownership, analyst recommendations, valuation, dividends and risk. Profitability This table compares Health Catalyst and Magnites net margins, return on equity and return on []